Weekly Cetuximab/RT Versus Weekly Cisplatin/RT in HPV-Associated Oropharyngeal Squamous Cell Carcinoma
Clinical trial NCT01855451 · UNKNOWN
Trial details
- NCT number
- NCT01855451
- Sponsor
- Trans Tasman Radiation Oncology Group
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-06-03
- Primary completion
- 2020-04-30
- Enrollment
- 189
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.